Qinghang Liu, MD, PhD
Title
Research Fellow, Division of Molecular Cardiovascular Biology
Email
qinghang.liu@cchmc.org
Phone
513-636-4809
Fax
513-636-5958
Credentials
MD: Taishan Medical College, Shandong, China, 1994
MS: Shanghai Medical University, Shanghai, China, 1997
PhD: University of Tennessee Health Sciences Center, Memphis, TN, 2004
Awards and Honors
- Young Investigator Award Finalist from International Society of Heart Research (ISHR). 2008.
- AHA Postdoctoral Fellowship. 2006-2008.
- Young Investigator Travel Award. 4th Annual Symposium of the American Heart Association Council on Basic Cardiovascular Sciences. July 2007, Keystone, CO. 2007.
- Award at the Poster Session, Seventh Annual Postdoctoral Fellows Research Forum, University of Cincinnati College of Medicine, Cincinnati, Ohio. 2005.
- Dorothy K and Daniel L. Gerwin Scholarship, the University of Tennessee Health Sciences Center, Memphis. 2002-2003.
- J Paul Quigley Memorial Scholarship, the University of Tennessee Health Sciences Center, Memphis. 2000-2001.
- Young Scholar Research Award (National), China Microcirculation Society. 1997.
- National Graduate Scholarship, Shanghai Medical University, Shanghai, China. 1995-1997.
- Excellent Medical Student Award, Taishan Medical College, Shangdong, China. 1990-1994.
Research
Defining novel signaling and transcriptional regulatory mechanisms underlying cardiac hypertrophy and heart failure using gene targeted and transgenic mice models; adenoviral-mediated gene transfer in cultured neonatal rat cardiomyocytes and other cell systems; hypertrophic signaling mechanisms
Research Grants and Contracts
American Heart Association Postdoctoral Fellowship, 2006-2008. Investigation of the role of apoptosis signal-regulated kinase 1 (ASK1) in regulation of cardiac growth and cell death in adult heart in vivo.
Publications, Most Recent
Liu Q, Busby JC, and Molkentin JD. Novel interaction between the TAK1-TAB1-TAB2 and the RCAN1-calcineurin regulatory pathways defines a signaling nodal control point.Nature Cell Biology. Jan 11, 2009. In press.
Liu Q, MacDonnell SM, Chen X, Lorenz J, Leitges M, Houser MR, and Molkentin JD. PKCα, but not PKCβ or PKCγ, regulates contractility and heart failure susceptibility: Implications for ruboxistaurin as a novel therapeutic approach.Circulation. In revision.
Liu Q, Wilkins BJ, Lee YJ, Ichijo H, and Molkentin JD. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.Mol Cell Biol. 2006; 26:3785-97.
Presentations, Most Recent
Liu Q. Young Investigator Award Finalist presentation. International Society of Heart Research (ISHR) Cincinnati, OH June 2008.
Liu Q, Busby JC, and Molkentin JD. Crosstalk between MCIP1-calcineurin and TAK1 signaling pathways regulates cardiomyocyte hypertrophy. The 4th Annual Symposium of the Council on Basic Cardiovascular Sciences. Keystone, CO. July 30-August 2, 2007
Liu Q, Wilkins BJ, Lee YJ, Ichijo H, and Molkentin JD. Crosstalk between ASK1 and calcineurin signaling pathways in cardiomyocytes. The 2nd Annual Symposium of the Council on Basic Cardiovascular Sciences. Keystone, CO., July 24-27, 2005.
Professional Organization Memberships
Special Interests
Cardiac hypertrophy and heart failure
